HIGH-VOLUME · HOSP-HEAVY

rosuvastatin Side Effects

rosuvastatin (also sold as Crestor) is HIGH-VOLUME in this FAERS book #31 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 31.1% mention hospitalization (60,611 reports).

Data updated 2026-05-15

194,743
FAERS reports

FAERS voluntary reports, 2004 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.

rosuvastatin: 31.1% mention hospitalization (60,611 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #31 of 524 by FAERS report count.

High-report extract for rosuvastatin (Crestor): 194,743 FAERS rows (2004-2025). Top named reactions: FATIGUE, NAUSEA, DYSPNOEA. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.

Counts from the openFDA FAERS extract (2004–2025). Stamps MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.

FATIGUE leads 11,700 of 194,743 reports

FATIGUE
11,700
NAUSEA
10,039
DYSPNOEA
9,208
DIARRHOEA
9,198
MYALGIA
8,784
PAIN
8,417
HEADACHE
7,796
DIZZINESS
7,718
ARTHRALGIA
7,255
ASTHENIA
7,203
PAIN IN EXTREMITY
6,768
MALAISE
6,483
FALL
6,006
VOMITING
5,828
ACUTE KIDNEY INJURY
5,250
WEIGHT DECREASED
5,200
MUSCLE SPASMS
4,974
PRURITUS
4,848

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 95,342 (53%)
Male 85,358 (47%)
Unknown 754

Age peak 45-64 (49,058 reports)

0-17 612 (0%)
18-44 5,735 (4%)
45-64 49,058 (37%)
65-74 42,871 (33%)
75+ 33,545 (25%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (11,716 reports, 6.0%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 4,212
PNEUMONIA 619
DYSPNOEA 592
ACUTE KIDNEY INJURY 583
RENAL FAILURE 518
CARDIAC ARREST 510
MYOCARDIAL INFARCTION 474
ASTHENIA 400
SEPSIS 388
NAUSEA 387
FATIGUE 386
DIARRHOEA 384
FALL 370
CARDIAC FAILURE 324
CHRONIC KIDNEY DISEASE 323
RESPIRATORY FAILURE 316
HYPOTENSION 296
COMPLETED SUICIDE 273
PYREXIA 271

Reactions in Hospitalization Reports

Hospitalization is HEAVY (60,611, 31.1% of the book). Top reactions in those rows:

Reaction Reports
DYSPNOEA 4,090
ACUTE KIDNEY INJURY 3,518
FALL 3,443
NAUSEA 3,384
DIARRHOEA 3,216
FATIGUE 3,191
PNEUMONIA 3,131
ASTHENIA 3,079
VOMITING 2,653
PAIN 2,459
RHABDOMYOLYSIS 2,438
MALAISE 2,346
HYPOTENSION 2,282
DIZZINESS 2,273
MYOCARDIAL INFARCTION 2,248
PYREXIA 2,194
HEADACHE 2,032
CHEST PAIN 2,028
WEIGHT DECREASED 1,981
How to read rosuvastatin FAERS figures (MEGA-CASE · DEATH-HEAVY · HOSP-HEAVY)

FAERS holds 194,743 voluntary reports linked to rosuvastatin (Crestor), 2004-2025. Death is listed on 11,716 (6.0%). Hospitalization appears on 60,611 (31.1%). Top co-reported indication: Product Used For Unknown Indication.

MEGA-CASE books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.

Read with rosuvastatin

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.